Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.


Strengths

● The prospective high growth for the next fiscal years is among the main assets of the company

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● The group's activity appears highly profitable thanks to its outperforming net margins.

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● Over the past year, analysts have regularly revised upwards their sales forecast for the company.

● Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● For several months, analysts have been revising their EPS estimates roughly upwards.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

● Over the past twelve months, analysts' opinions have been strongly revised upwards.


Weaknesses

● The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.

● Based on current prices, the company has particularly high valuation levels.

● The company appears highly valued given the size of its balance sheet.

● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.

● The average consensus view of analysts covering the stock has deteriorated over the past four months.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.